Carla V. H.
- Country
- The Netherlands
- Department
- Oncology
Research Overview
- Phase I Evaluation of FS222 for Safety and Efficacy in Patients with Advanced Malignancies
- Dose-Escalation Study of BI 3810944 in Patients with Advanced Melanoma and Solid Tumors
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with recurrent and/or metastatic salivary duct carcinoma – DUCT study
Data & Insights
Has run more than one trial at 91 of 214 partner sites.
Specializations
Head and Neck Cancer Research
The investigator specializes in treating various forms of head and neck malignancies, with particular focus on squamous cell carcinoma and salivary duct carcinoma.
- Advanced HNSCC Treatment Approaches
- Salivary Gland Cancer Therapeutics
- Recurrent and Metastatic Disease Management
Their work encompasses both localized and systemic treatment strategies for head and neck cancers.
Novel Therapeutic Development
The investigator is involved in evaluating innovative treatment combinations and targeted therapies for various cancer types, including studies with antibody-based treatments and novel compounds.
- First-in-Human Studies
- Combination Therapy Approaches
- Immunotherapy Applications
Their research includes assessment of emerging therapeutic agents across multiple cancer indications.
Solid Tumor Oncology
The investigator conducts research in advanced solid tumors, with expertise in treating HER2-positive malignancies and exploring novel treatment paradigms.
- Colorectal Cancer Treatment
- Breast Cancer Therapeutics
- Advanced Stage Disease Management
Their work focuses on developing treatment strategies for patients with locally advanced or metastatic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.